Jeffrey Stavenhagen
Technik-/Wissenschafts-/F&E-Leiter bei DIANTHUS THERAPEUTICS, INC.
Profil
Jeffrey Stavenhagen is currently the Chief Scientific Officer at Dianthus Therapeutics, Inc. He previously held the same position at Therini Bio, Inc. from 2019 to 2023.
He obtained a doctorate degree from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Jeffrey Stavenhagen
| Unternehmen | Position | Beginn |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.11.2023 |
Ehemalige bekannte Positionen von Jeffrey Stavenhagen
| Unternehmen | Position | Ende |
|---|---|---|
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2023 |
Ausbildung von Jeffrey Stavenhagen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Commercial Services |
